Angiotensin II Inhibits Insulin Receptor Signaling in Adipose Cells

Area of Science:

• Endocrinology
• Molecular Biology
• Metabolic Research

Background:

• Angiotensin II (Ang II) regulates insulin signaling in cardiovascular and metabolic tissues.
• The specific role of Ang II in adipose cells' insulin signaling is not fully understood.

Purpose of the Study:

• To investigate the effect of Ang II on insulin signaling pathways in 3T3-L1 adipocytes.
• To elucidate the mechanism by which Ang II influences insulin-stimulated glucose uptake and insulin receptor (IR) activity.

Main Methods:

• Utilized 3T3-L1 adipocytes and isolated adipocytes for experiments.
• Examined insulin-induced insulin receptor (IR) and insulin receptor substrate-1 (IRS-1) phosphorylation (tyrosine and serine).
• Assessed Akt activation, glucose uptake, and protein kinase C (PKC) isoform activity and association with the IR.

Main Results:

• Ang II inhibited insulin-stimulated tyrosine phosphorylation of IR and IRS-1, Akt activation, and glucose uptake in a time-dependent manner.
• Ang II increased serine phosphorylation of the IR, but not IRS-1, suggesting IR as the primary site of desensitization.
• PKC inhibition restored insulin signaling, and Ang II activated multiple PKC isoforms (PKCα/βI/βII/δ), with PKCβII showing high interaction with the IR.

Conclusions:

• Angiotensin II negatively impacts insulin signaling in adipocytes, potentially leading to insulin resistance.
• Protein kinase C (PKC) activation by Ang II is a key mechanism underlying this insulin desensitization in fat cells.